Roehampton University Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2010
NCT02172859
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Roehampton University | School of Human & Life Sciences, Roehampton University, Holybourne Avenue London SW15 4JD, UK

Active Ingredients

Drugs in Phase 2 Trials (1)

tryptophan (1 trial)

Drugs in Other Trials (3)

chromium picolinate (1 trial)

glucomannan (1 trial)

oligofructose (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4